Targeting androgen receptor signaling to enhance cancer immunotherapy
Trends in Pharmacological Sciences · 2026-11 · 47 (11) · 1252-1267
DOI: 10.1016/j.tips.2025.11.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-11. Verfasst von David A Bader und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Division of Medical Oncology, Duke University School of Medicine, Durham…. Hauptthemen laut MEDLINE: Receptors, Androgen, Immunotherapy, Neoplasms, Androgen Receptor Antagonists. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Conquer Cancer Foundation, American Society of Clinical Oncology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Division of Medical Oncology, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Duke Molecular Phys…
- Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
- Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
- Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Duke Molecular Physiology Institute, Durham, NC, USA; Pharmacology and Cancer Biology, Duke University…
Förderung
- NCI NIH HHS
- Conquer Cancer Foundation
- American Society of Clinical Oncology
- National Institutes of Health National Cancer Institute
Zitieren
APA
Bader, D. A., Chakraborty, B., McDonnell, D. P., & Hirschey, M. D. (2026). Targeting androgen receptor signaling to enhance cancer immunotherapy. Trends in Pharmacological Sciences, 47(11), 1252-1267. https://doi.org/10.1016/j.tips.2025.11.003
Vancouver
Bader DA, Chakraborty B, McDonnell DP, Hirschey MD. Targeting androgen receptor signaling to enhance cancer immunotherapy. Trends in Pharmacological Sciences. 2026;47(11):1252-1267. doi:10.1016/j.tips.2025.11.003
BibTeX
@article{Bader2026,
author = {Bader, David A and Chakraborty, Binita and McDonnell, Donald P and Hirschey, Matthew D},
title = {Targeting androgen receptor signaling to enhance cancer immunotherapy},
journal = {Trends in Pharmacological Sciences},
year = {2026},
volume = {47},
number = {11},
pages = {1252--1267},
doi = {10.1016/j.tips.2025.11.003}
}
EUVIMED